SK160299A3 - Multicyclic erythromycin derivatives - Google Patents

Multicyclic erythromycin derivatives Download PDF

Info

Publication number
SK160299A3
SK160299A3 SK1602-99A SK160299A SK160299A3 SK 160299 A3 SK160299 A3 SK 160299A3 SK 160299 A SK160299 A SK 160299A SK 160299 A3 SK160299 A3 SK 160299A3
Authority
SK
Slovakia
Prior art keywords
substituted
hydrogen
compound
group
alkyl
Prior art date
Application number
SK1602-99A
Other languages
English (en)
Slovak (sk)
Inventor
Yat Sun Or
George W Griesgraber
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SK160299A3 publication Critical patent/SK160299A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK1602-99A 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives SK160299A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86545397A 1997-05-29 1997-05-29
PCT/US1998/010501 WO1998054197A1 (en) 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives

Publications (1)

Publication Number Publication Date
SK160299A3 true SK160299A3 (en) 2000-06-12

Family

ID=25345545

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1602-99A SK160299A3 (en) 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives

Country Status (26)

Country Link
EP (1) EP0984975B1 (xx)
JP (1) JP4368950B2 (xx)
KR (1) KR20010013041A (xx)
CN (1) CN1258299A (xx)
AR (1) AR013081A1 (xx)
AT (1) ATE238330T1 (xx)
AU (1) AU7591298A (xx)
BG (1) BG103985A (xx)
BR (1) BR9809489A (xx)
CA (1) CA2290421C (xx)
CO (1) CO4950620A1 (xx)
DE (1) DE69813798T2 (xx)
DK (1) DK0984975T3 (xx)
ES (1) ES2197472T3 (xx)
HU (1) HUP0004809A3 (xx)
IL (1) IL132482A0 (xx)
MX (1) MXPA99011001A (xx)
NO (1) NO995842L (xx)
NZ (1) NZ500531A (xx)
PL (1) PL337066A1 (xx)
PT (1) PT984975E (xx)
SI (1) SI0984975T1 (xx)
SK (1) SK160299A3 (xx)
TR (1) TR199902820T2 (xx)
WO (1) WO1998054197A1 (xx)
ZA (1) ZA984488B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE250076T1 (de) * 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
US20100035832A1 (en) * 2005-01-12 2010-02-11 Alpharma Aps Macrolides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE145212T1 (de) * 1992-04-22 1996-11-15 Taisho Pharmaceutical Co Ltd 5-0-desosaminylerythronolide a derivate
ES2218604T3 (es) * 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.

Also Published As

Publication number Publication date
ES2197472T3 (es) 2004-01-01
JP4368950B2 (ja) 2009-11-18
DK0984975T3 (da) 2003-08-11
PL337066A1 (en) 2000-07-31
AR013081A1 (es) 2000-12-13
WO1998054197A1 (en) 1998-12-03
JP2002500669A (ja) 2002-01-08
EP0984975A1 (en) 2000-03-15
EP0984975B1 (en) 2003-04-23
NO995842L (no) 2000-01-26
CO4950620A1 (es) 2000-09-01
BG103985A (en) 2000-07-31
NZ500531A (en) 2001-07-27
DE69813798D1 (en) 2003-05-28
DE69813798T2 (de) 2004-02-19
HUP0004809A3 (en) 2001-11-28
ATE238330T1 (de) 2003-05-15
CN1258299A (zh) 2000-06-28
TR199902820T2 (xx) 2000-04-21
MXPA99011001A (es) 2003-09-10
PT984975E (pt) 2003-09-30
AU7591298A (en) 1998-12-30
CA2290421A1 (en) 1998-12-03
NO995842D0 (no) 1999-11-29
IL132482A0 (en) 2001-03-19
ZA984488B (en) 1998-12-02
SI0984975T1 (en) 2004-02-29
KR20010013041A (ko) 2001-02-26
CA2290421C (en) 2007-05-08
BR9809489A (pt) 2000-06-20
HUP0004809A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
US5922683A (en) Multicyclic erythromycin derivatives
DE69733369T2 (de) 6-o-Substituierte Ketoliden mit antibakteriellen Wirking
CA2253338C (en) 6-o-substituted erythromycins and method for making them
CZ303474B6 (cs) 6-O-substituovaný ketolidový derivát erythromycinu, zpusob jeho prípravy, jeho použití a farmaceutická kompozice ho obsahující
AU737310B2 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
EP1027361B1 (en) 6,11-bridged erythromycin derivatives
SK286397B6 (sk) 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom
SK3032000A3 (en) 6,9-bridged erythromycin derivatives
US6420535B1 (en) 6-O-carbamate ketolide derivatives
US20020019355A1 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1181300B1 (en) 6-o-carbamate ketolide derivatives
CA2301642A1 (en) 3-descladinose 6-o-substituded erythromycin derivatives
SK160299A3 (en) Multicyclic erythromycin derivatives
JP2003501439A5 (xx)
US6569836B2 (en) 6-O-alkyl-2-nor-2-substituted ketolide derivatives
EP1233971B1 (en) 6-o-alkyl-2-nor-2-substituted ketolide derivatives
EP1259923B1 (en) Anti-infective agents useful against mulitidrug-resistant strains of bacteria
AU714176B2 (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
CZ407399A3 (cs) Multicyklické deriváty erythromycinu
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
CZ20001394A3 (cs) Erythromycinové deriváty s 6,11-přemostěním
CZ20001045A3 (cs) 3-N-módilikováné 6-O-substituované ketolidové deriváty erytromycinu